Days
Hours
Minutes
Summer shares her ocular melanoma story and why she joined the #CUREOM Unite! campaign to support the development of a national ocular melanoma patient registry.
Last month I was invited to participate in a summit meeting for Vice President Biden’s Cancer Moonshot program, the aim of which is to achieve 10 years of progress in...
Each year, Kayla Jensen, 9, looks forward to the trip she and her family make from Lewistown, Montana, to Denver, Colorado, for the annual Miles for Melanoma 5k run/walk. T...
Washington, DC and Los Angeles, CA, April 2016 – The Melanoma Research Foundation (MRF) today announced it is partnering with world-renowned actor and long-time melan...
Six years ago I noticed a dark line in my finger nail that continued to worsen over the course of the year. After my nail started lifting from the nail bed, I went to see m...
#GivingTuesday is TOMORROW! Join Sheila in Supporting the MRF. #GivingTuesday is in less than 24 hours! Your tax-deductible gift received on #GivingTuesday will help...
Ocular melanoma survivor Anne Marie Montijo reflects on the passing of Dr. Oliver Sacks and her own goal to live each day with a spirit of gratitude.
The results are in and #CUREOM Unite! was a tremendous success! Thank you to everyone who gave so generously to this campaign to further patient-centered ocular melanoma (O...
Today the FDA approved Amgen’s drug, Imlygic (Talimogene Laherparepvec or T-VEC), for the treatment of unresectable Stage IIIB, IIIC or IV metastatic melanoma, bringing a...
Guest blogger Connie Popp shares her experience as an ocular melanoma caregiver, advocate and participant in Miles for Melanoma in support of the CURE OM Unite! campaign. 3 Minute Read
Leanda Cave Partners with the Melanoma Research Foundation to Raise Awareness of the Deadliest Form of Skin Cancer WASHINGTON, D.C.— Four-time Triathlon World ...
Guest blogger Frank Nichols shares his story as an ocular melanoma patient, advocate and participant in Miles for Melanoma NYC.
Dec 02, 2025 ET
Dec 13, 2025 CT
